Azitra is trading 5.6% higher at $0.14 following a fresh wave of bullish analyst sentiment and updated price targets.
- The move follows updated Strong Buy ratings and above-market price targets published on August 3, 2026, which continue to drive speculative interest.
- Gains are being further supported by a broader rally across the biotech sector and overall market strength.